Updated:
AshHill Biomedical
AshHill is a private investment firm with a specialized focus on the biomedical sector and participating in its portfolio companies in active management roles,...
Overview
AshHill is a private investment firm with a specialized focus on the biomedical sector and participating in its portfolio companies in active management roles, as well as scientific and support services. Its mission is to discover, analyze and invest in start-up, seed-stage and established companies that are working to develop medical innovations.
General information
Firm type
Private Equity
Year founded
2011
Location
Region
North America
Country
United States
City
Cincinnati
Corporate office
Cincinnati, OH, United States
Sector focus
Frequently asked questions
What is AshHill Biomedical's investment focus?
The firm invests primarily in early-stage medical device and diagnostic companies. AshHill targets the translational gap between preclinical validation and regulatory submission, with an emphasis on asset-heavy biomedical products that require FDA 510(k) clearance or de novo classification. The firm also evaluates digital health opportunities when they are paired with a regulated diagnostic or device platform.
Where does AshHill Biomedical source its deals?
AshHill is positioned to source deals from the academic medical centers and research universities concentrated in the Ohio Valley and broader Midwest. The firm's Cincinnati headquarters places it within reach of significant spinout activity from institutions including the Cleveland Clinic, Ohio State University, and the University of Cincinnati Academic Health Center, though specific sourcing arrangements have not been publicly detailed.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: